Profiel
Andrew Satlin worked as the Director of Geriatric Psychiatry at McLean Hospital, Inc. from 1980 to 1997.
He then worked as the EVP & Global Head of Medicine Creation Strategy at Eisai, Inc. from 2008 to 2017.
After that, he served as the Chief Medical Officer & Executive Vice President at Intra-Cellular Therapies, Inc. from 2017 to 2020.
Prior to his work in the industry, he was an Assistant Professor at Harvard Medical School.
Satlin received his undergraduate degree from Yale University and his doctorate from Harvard Medical School.
Eerdere bekende functies van Andrew Satlin
| Bedrijven | Functie | Einde |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Hoofd Techniek/Wetenschap/O&O | 28-10-2020 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01-11-2017 |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Corporate Officer/Principal | 01-01-1997 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Andrew Satlin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
















